FGFR4 promotes stroma-induced epithelial-to-mesenchymal transition in colorectal cancer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23943801.
- Also identified by DOI 10.1158/0008-5472.CAN-12-4718.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tumor cells evolve by interacting with the local microenvironment; however, the tumor-stroma interactions that govern tumor metastasis are poorly understood. In this study, proteomic analyses reveal that coculture with tumor-associated fibroblasts (TAF) induces significant overexpression of FGFR4, but not other FGFRs, in colorectal cancer cell lines. Mechanistic study shows that FGFR4 plays crucial roles in TAF-induced epithelial-to-mesenchymal transition (EMT) in colorectal cancer cell lines. Accumulated FGFR4 in cell membrane phosphorylates β-catenin, leading to translocation of β-catenin into the nucleus. Further, TAF-derived CCL2 and its downstream transcription factor, Ets-1, are prerequisites for TAF-induced FGFR4 upregulation. Furthermore, FGFR4-associated pathways are shown to be preferentially activated in colorectal tumor samples, and direct tumor metastasis in a mouse metastasis model. Our study shows a pivotal role of FGFR4 in tumor-stroma interactions during colorectal cancer metastasis, and suggests novel therapeutic opportunities for the treatment of colorectal cancer.
Medical subject headings
- Colorectal Neoplasms
- Epithelial-Mesenchymal Transition
- Fibroblasts
- Gene Expression Regulation, Neoplastic
- Lung Neoplasms
- Receptor, Fibroblast Growth Factor, Type 4
- Stromal Cells